In May 2025, the U.S. and China agreed to reduce tariffs on each other’s goods from 125% to 10% after Geneva negotiations, marking a significant de-escalation in their trade dispute. The deal, effective May 14, pauses further retaliatory measures for 90 days, fostering talks to address the $300 billion U.S.-China goods trade deficit recorded in 2024.

Key Terms

The U.S. lowers its “reciprocal” tariff to 10%, retaining a 20% tariff tied to fentanyl enforcement, while China matches the 10% reduction. Both sides will suspend non-tariff measures and pre-April 2025 tariffs, except those for national security. A bilateral mechanism, led by Treasury Secretary Scott Bessent and Vice Premier He Lifeng, will guide negotiations for a long-term framework.

Economic and Policy Context

The agreement triggered a U.S. stock futures rally, reflecting optimism for reduced inflation and increased exports. China’s commitment to curb fentanyl precursor exports addresses U.S. concerns. The deal follows a U.S.-U.K. trade pact, highlighting a focus on bilateral agreements to strengthen American industries and global economic stability.

Implications

The tariff cuts offer businesses and consumers relief, but the 90-day window will test both nations’ commitment to sustained cooperation. Successful talks could reshape global trade dynamics, while stakeholders monitor impacts on supply chains, prices, and U.S. manufacturing competitiveness.